Sanford Burnham Prebys Medical Discovery Institute-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Sanford Burnham Prebys Medical Discovery Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013365
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sanford Burnham Prebys Medical Discovery Institute (Sanford Burnham) is a non-profit public benefit institute that offers medical research services. The institute offers research programs in the field of tumor initiation and maintenance, cancer metabolism and signaling networks, tumor microenvironment and cancer immunology, degenerative diseases, immunity and pathogenesis, human genetics development, aging and regeneration, bioinformatics and structural biology, cardiovascular metabolism, integrative metabolism, and genomic control of metabolism. It offers stem cell research and drug discovery technologies. The institute’s technology centers include conrad prebys center for chemical genomics, stem cell research center and translational research institute, among others. It operates in La Jolla and Orlando, the US. Sanford-Burnham is headquartered in La Jolla, California, the US.

Sanford Burnham Prebys Medical Discovery Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Takeda Pharma Enters into Agreement with Sanford-Burnham 11
Eli Lilly to Enter into Research Agreement with Sanford Burnham 12
Sanford Burnham Enters into Co-Development Agreement with Daiichi Sankyo 13
Sanford-Burnham Medical Research Institute Enters Into Research Agreement With Pfizer 14
Mayo Clinic Enters Into Research Agreement With Sanford-Burnham Medical Research Institute 15
Sanford Burnham Enters into Agreement With 60 Degrees Pharma 16
Sanford-Burnham And Florida Hospital Extend Research Agreement With Takeda 17
Sanford-Burnham Medical Enters Into Agreement With Intrexon For Stem Cell Research 18
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 19
Sanford-Burnham Medical Research Institute Enters Into Agreement With Pfizer 20
Sanford-Burnham Medical Enters Into Collaboration With Ortho-McNeil-Janssen Pharma 21
Licensing Agreements 22
Tarrex Biopharma Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 22
Clementia Pharma to Enter into License Agreement with Sanford Burnham Prebys Medical 23
EnduRx Pharma Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 24
Sanford Burnham Prebys Medical Discovery Institute – Key Competitors 25
Sanford Burnham Prebys Medical Discovery Institute – Key Employees 26
Sanford Burnham Prebys Medical Discovery Institute – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Government and Public Interest 28
Sep 26, 2017: SBP scientist receives $10.8 million grant to advance potential drug for substance abuse 28
Aug 08, 2016: Scientists discover potential avenue to treating type 2 diabetes at early stages 29
May 06, 2016: Researchers Find a Way to Deliver Drugs to the Placenta to Support Healthier Pregnancies 30
Feb 17, 2016: Researchers Reveal New Links Between Heart Hormones Obesity and Diabetes 31
Product News 32
Mar 14, 2016: New drug combination shows promise against childhood brain cancer 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Key Facts 2
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sanford Burnham Prebys Medical Discovery Institute, Deals By Therapy Area, 2011 to YTD 2017 8
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Takeda Pharma Enters into Agreement with Sanford-Burnham 11
Eli Lilly to Enter into Research Agreement with Sanford Burnham 12
Sanford Burnham Enters into Co-Development Agreement with Daiichi Sankyo 13
Sanford-Burnham Medical Research Institute Enters Into Research Agreement With Pfizer 14
Mayo Clinic Enters Into Research Agreement With Sanford-Burnham Medical Research Institute 15
Sanford Burnham Enters into Agreement With 60 Degrees Pharma 16
Sanford-Burnham And Florida Hospital Extend Research Agreement With Takeda 17
Sanford-Burnham Medical Enters Into Agreement With Intrexon For Stem Cell Research 18
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 19
Sanford-Burnham Medical Research Institute Enters Into Agreement With Pfizer 20
Sanford-Burnham Medical Enters Into Collaboration With Ortho-McNeil-Janssen Pharma 21
Tarrex Biopharma Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 22
Clementia Pharma to Enter into License Agreement with Sanford Burnham Prebys Medical 23
EnduRx Pharma Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 24
Sanford Burnham Prebys Medical Discovery Institute, Key Competitors 25
Sanford Burnham Prebys Medical Discovery Institute, Key Employees 26
Sanford Burnham Prebys Medical Discovery Institute, Other Locations 27

★海外企業調査レポート[Sanford Burnham Prebys Medical Discovery Institute-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Polar Power Inc (POLA):企業の財務・戦略的SWOT分析
    Polar Power Inc (POLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Nayara Energy Ltd:企業の戦略的SWOT分析
    Nayara Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • MRI Interventions Inc (MRIC)-医療機器分野:企業M&A・提携分析
    Summary MRI Interventions Inc (MRI Interventions) is a medical device company that develops and commercializes platforms for performing invasive surgical procedures. The company’s product platforms include clearpoint system, which is used for minimally invasive surgical procedures in the brain; and …
  • ARCA biopharma Inc (ABIO):製薬・医療:M&Aディール及び事業提携情報
    Summary ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment …
  • Navitas Ltd:企業の戦略的SWOT分析
    Navitas Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Taris Biomedical LLC:企業のM&A・事業提携・投資動向
    Taris Biomedical LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Taris Biomedical LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • UCO Bank:企業の戦略・SWOT・財務情報
    UCO Bank - Strategy, SWOT and Corporate Finance Report Summary UCO Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Heliatek GmbH:電力:M&Aディール及び事業提携情報
    Summary Heliatek GmbH (Heliatek) is a solar energy company that manufactures and constructs organic photovoltaics. The company manufactures modules on flexible substrates utilizing a roll-to-roll production process. Its products include OPV oligomers, OPV polymers, and OPV dye-sensitized solar cells …
  • Ontario Power Generation Inc:企業の戦略的SWOT分析
    Ontario Power Generation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Sumitomo Mitsui Financial Group, Inc.:企業のM&A・事業提携・投資動向
    Sumitomo Mitsui Financial Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sumitomo Mitsui Financial Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Institute for Research in Immunology and Cancer-製薬・医療分野:企業M&A・提携分析
    Summary Institute for Research in Immunology and Cancer (IRICoR), a subsidiary of University of Montreal is a non-profit research institute that offers drug discovery and commercialization services. The institute offers discovery, development and commercialization of novel drugs in oncology. It has …
  • Aitken Spence Hotel Holdings PLC:企業の戦略・SWOT・財務情報
    Aitken Spence Hotel Holdings PLC - Strategy, SWOT and Corporate Finance Report Summary Aitken Spence Hotel Holdings PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Hitachi Ltd (6501)-エネルギー分野:企業M&A・提携分析
    Summary Hitachi, Ltd. (Hitachi) is a multinational company with operations in sectors such as engineering and electronics, nuclear, transportation and industrial systems. It manufactures and sells information and telecommunication systems, power systems, social infrastructure and industrial systems, …
  • TAP Biosystems Ltd-製薬・医療分野:企業M&A・提携分析
    Summary TAP Biosystems Ltd (TAP), a subsidiary of Sartorius Stedim Biotech GmbH is a medical laboratory that provides laboratory and pharmaceutical equipment. The laboratory offers products such as single-use mini bioreactor systems and automated cell culture systems. It also provides labware, consu …
  • Getlink SE:企業の戦略・SWOT・財務分析
    Getlink SE - Strategy, SWOT and Corporate Finance Report Summary Getlink SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Foundation Medicine Inc (FMI):製薬・医療:M&Aディール及び事業提携情報
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd, is a molecular information products provider. The company provides molecular information and cancer research programs. It offers clinical products such as FoundationOne for solid tumors and FoundationOne …
  • Society for Worldwide Interbank Financial Telecommunication:企業の戦略的SWOT分析
    Society for Worldwide Interbank Financial Telecommunication - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, k …
  • Yamato Holdings Co Ltd (9064):企業の財務・戦略的SWOT分析
    Yamato Holdings Co Ltd (9064) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • ImaBiotech SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary ImaBiotech SAS (ImaBiotech) is a contract research organization that offers mass spectrometry imaging services. The organization’s software products include quantinetix and multimaging. It offers services such as biomarker discovery, consulting and training, screening studies, target engagem …
  • Neiman Marcus Group LTD LLC:企業の戦略・SWOT・財務分析
    Neiman Marcus Group LTD LLC - Strategy, SWOT and Corporate Finance Report Summary Neiman Marcus Group LTD LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆